Skip to main content
. 2022 Feb 21;8:793445. doi: 10.3389/fmolb.2021.793445

FIGURE 2.

FIGURE 2

Relationship between CD93 expression and patient prognosis. (A,B) Correlation between the expression of CD93 and overall survival (OS) and disease-specific survival (DSS) in multiple tumor types based on The Cancer Genome Atlas (TCGA). (C) Difference in the OS between the CD93 high and low expression groups in four cancer types (KIRP, KIRC, UVM, and LGG). (D) Difference in the DSS between the CD93 high and low expression groups in four cancer types (KIRP, KIRC, UVM, and LGG).